Cellestia logo

Cellestia

Cellestia is a bio-pharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.

1

Funding Rounds

$20.0m

Money raised

Overview

Cellestia is a bio-pharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.

Funding series

Funding Series Analysis

The company Cellestia has raised a total of $20m in funding over 1 rounds.

Key Insights:

  • Cellestia Biotech Series B round, December 2019: $20m
Cellestia logo
Cellestia Biotech Series B round, December 2019 $20m